CD8A and COVID-19: This could imply that CD8+CD57+ T cells exhibiting enhanced cytotoxic potencies, and impaired proliferative capability, are recruited to the peripheral blood and the unresolved chronic inflammatory state is maintained in severe convalescents long after recovery from COVID-19.